BioCentury
ARTICLE | Clinical News

Brovana arformoterol tartrate pulmonary data

October 29, 2007 7:00 AM UTC

In a 4-week, double-blind study in 215 patients, Brovana did not prolong the QTc interval. Patients received twice-daily doses of 5, 10 or 25 µg Brovana or placebo for 2 weeks, followed by once-daily ...